About Cube Biotech
Unleashing the power of proteins for research and progress, Cube Biotech supports the pharmaceutical and biotechnical community with all its scientific expertise.
By leveraging the latest technologies and techniques, Cube is able to provide a comprehensive range of products and services that address the full spectrum of protein research, from expression and purification to characterization and stabilization.
In January 2025, the company acquired IBA Lifesciences, combining complementary strengths in protein purification and tags/affinity systems to broaden its offering and global reach.
The opportunity
Reporting to the CEO, the CCO will own Cube Biotech’s global commercial and marketing strategy—turning its scientific strengths into sustainable revenue at scale. He/she will partner closely with the different teams, while structuring a commercial organization that has grown quickly and suddenly over the past few years.
Key responsibilities
Team & scope
Requirements
Background & experience required

With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Animal & Environmental Health, Healthcare IT, Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.
ARCHIMED manages €9 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner.
Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.